Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gaurav Chauhan

Anesthesiology Detroit, MI Medical Doctor

NPI 1972979771 CMS profile 1328360

2799 W Grand Blvd, Dept. Of Anesthesiology, Henry Ford Hospital, Detroit, MI 48202

Open in the dashboard

General payments

$4,700

72 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gaurav Chauhan of Detroit, MI is reported in the CMS Open Payments database as having received $4,700 across 72 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $94 4
2023 General $822 13
2022 General $627 16
2021 General $269 6
2020 General $856 11
2019 General $2,032 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gaurav Chauhan
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Gaurav Chauhan were reported at $94. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Gaurav Chauhan Anesthesiology median Middle half National median
2019 $2,032 $72 $23–$151 $163
2020 $856 $36 $17–$120 $114
2021 $269 $49 $21–$135 $132
2022 $627 $52 $22–$144 $149
2023 $822 $53 $23–$143 $160
2024 $0 $55 $25–$150 $164
2025 $94 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nevro Corp. $2,457 26 payments
  2. Boston Scientific Corporation $767 16 payments
  3. Abbott Laboratories $591 10 payments
  4. Medtronic USA, Inc. $276 5 payments
  5. Medtronic, Inc. $247 6 payments
  6. Relievant Medsystems, Inc. $141 2 payments
  7. COMSORT, Inc $100 1 payment
  8. Teleflex LLC $29 1 payment
  9. SPR Therapeutics, Inc $29 2 payments
  10. Masimo Corporation $28 1 payment
  11. Other $37 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,751 65 payments
  2. Travel and Lodging $850 6 payments
  3. Consulting Fee $100 1 payment
Products named General payments · program years 2019–2025
  1. Senza Spinal Cord Stimulation System $1,919 19 payments
  2. PROCLAIM $390 4 payments
  3. Senza $324 4 payments
  4. General - Pain Management $218 6 payments
  5. Omnia $214 3 payments
  6. INTELLIS $180 3 payments
  7. VANTA ADAPTIVESTIM $146 4 payments
  8. Intracept $141 2 payments
  9. Octrode SCS Leads $140 1 payment
  10. GENERAL PAIN MANAGEMENT $116 2 payments
  11. Other $676 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

248

Median for Anesthesiology: 322

Drug cost

$3,214

Median for Anesthesiology: $8,738

Branded share of claims

0%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 111 $1,528
Baclofen Generic 25 $464
Duloxetine Hcl Generic 21 $374
Memantine Hcl Generic 27 $318
Pregabalin Generic 14 $259
Cyclobenzaprine Hcl Generic 36 $146
Methocarbamol Generic 14 $124

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 81 billing codes

Paid by Medicare

$40,501

Medicare's payments for the services billed

Medicare patients

381

Average age 72

Services billed

438

193 women, 188 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Diabetes 41%
Chronic kidney disease 37%
Ischemic heart disease 36%
Depression 35%
Heart failure 29%
COPD 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

72 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record